Streetbeat News

Products Services

SOFI

The article discusses the potential of investing in SoFi Technologies, comparing it to early investments in successful companies like Apple and Nvidia. It suggests that buying SoFi stock today could lead to significant long-term gains.

Portfolio Pulse from

December 14, 2024 | 8:45 am

RBLX

Roblox (RBLX) has been experiencing a surge in its stock price, trading near its 52-week high. The company's gaming platform is popular among young kids, contributing to its recent sales growth.

Portfolio Pulse from

December 14, 2024 | 8:30 am

SWK

Stanley Black & Decker, a major tool-maker, is down 61% from its all-time high. The company, known for brands like DeWalt and Craftsman, may see a turnaround by 2025.

Portfolio Pulse from

December 14, 2024 | 8:15 am

MTH

Meritage Homes Corporation is rated as a buy due to strong earnings growth prospects and favorable macro conditions, such as tight housing supply and high mortgage rates. The company's strategy of offering quick, move-in ready homes with a 60-day closing guarantee is well-suited to current market demands. Potential risks include tighter regulations on home financing and supply chain pressures.

Portfolio Pulse from

December 14, 2024 | 6:45 am

ACN

Accenture faces challenges with slow growth and IT budget reallocations towards AI, impacting its recent performance. Despite a strong historical record and predictable revenue, its premium valuation and moderate growth prospects lead to a Sell rating.

Portfolio Pulse from

December 14, 2024 | 5:45 am

CURV

Torrid Holdings (CURV) faces challenges with declining demand and an expensive valuation. The company's 3Q24 revenue dropped by 4.2% year-over-year, marking the ninth consecutive quarter of negative comparable sales growth and missing consensus estimates. Management needs to demonstrate its ability to accelerate comparable sales growth in 4Q24, particularly with new product launches and the holiday shopping season.

Portfolio Pulse from

December 14, 2024 | 5:45 am

HROW

Harrow has relaunched Triesence, a preservative-free corticosteroid, to meet a critical need in ophthalmology. The product's unique formulation offers a safer alternative to existing treatments, positioning Harrow for significant market growth.

Portfolio Pulse from

December 14, 2024 | 5:30 am

GM

GOOGL

General Motors (GM) has decided to exit the global robotaxi business by scrapping its Cruise division, saving $1 billion annually. This decision comes after investing $10 billion in Cruise since 2016, due to competition from Alphabet's Waymo and Amazon, as well as operational challenges. GM will now focus on restructuring its BEV business, China operations, and returning cash to shareholders through buybacks and dividends.

Portfolio Pulse from

December 14, 2024 | 1:00 am

NFLX

Netflix continues to dominate the streaming industry, maintaining a competitive edge over its rivals. The Motley Fool Scoreboard episode provides insights into Netflix's market trends and potential investment opportunities.

Portfolio Pulse from

December 14, 2024 | 12:15 am

NBIX

Neurocrine Biosciences has received FDA approval for CRENESSITY, a first-in-class treatment for classic congenital adrenal hyperplasia (CAH). This marks the first new treatment in 70 years for CAH, supported by extensive clinical trials. The drug will be available in a week.

Portfolio Pulse from

December 14, 2024 | 12:15 am